• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Doxorubicin (Adriamycin) Lyophilized Powder

 Status: Currently in Shortage

 » Date first reported: 12/02/2011
 » Therapeutic Categories: Oncology; Pediatric

Bedford Laboratories (Reverified 07/09/2014)

Company Contact Information:
800-562-4797

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg vials (NDC 55390-0231-01) Unavailable Shortage: Pending Manufacturing Change or Addition. Availability of products are updated on the Bedford Laboratories website. Other
50 mg vials (NDC 55390-0233-01) Unavailable Shortage: Pending Manufacturing Change or Addition. Availability of products are updated on the Bedford Laboratories website. Other
20 mg vials (NDC 55390-0232-10) Unavailable Shortage: Pending Manufacturing Change or Addition. Availability of products are updated on the Bedford Laboratories website. Other

Mylan Institutional (Reverified 09/16/2014)

Company Contact Information:
888-258-4199

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10mg vials (NDC 0069-0170-01) Unavailable. Temporarily discontinued until 2015. Demand increase for the drug
50mg vials (NDC 67457-436-50) Unavailable. Estimated Recovery: November 2014
-
-